EQS-CMS: Fresenius Medical Care AG : Release of a capital market information

Fresenius Medical Care AG: Share buyback Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Share buyback – Interim Report In the period from September 21, 2026 to September 25, 2026 (each inclusive), 71,090 shares were bought back within the framework of the first tranche of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on May 28, 2026, pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Shares were bought back as follows:

Date	Acquired shares (number)	Weighted average price (in EUR)	Transaction volume (in EUR)	Trading venue
21 September 2026	30,000	38.9652	1,168,956.00	XETR
23 September 2026	40,000	39.2727	1,570,908.00	XETR
24 September 2026	1,000	39.3446	39,344.60	XETR
25 September 2026	90	39.4366	3,549.29	XETR

A total of 9,055,265 shares has been acquired within the framework of the first tranche of the share buyback. The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG. Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.